These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35371111)

  • 1. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.
    de Krijger M; Hageman IL; Li Yim AYF; Verhoeff J; Garcia Vallejo JJ; van Hamersveld PHP; Levin E; Hakvoort TBM; Wildenberg ME; Henneman P; Ponsioen CY; de Jonge WJ
    Front Immunol; 2022; 13():840935. PubMed ID: 35371111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.
    Kempinska-Podhorodecka A; Adamowicz M; Ostrycharz E; Chmielarz M; Wójcicki M; Milkiewicz P; Milkiewicz M
    Sci Rep; 2021 May; 11(1):10134. PubMed ID: 33980925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis.
    Wang MH; Friton JJ; Rebert N; Monroe K; Nix BD; Fiocchi C; Raffals LE; Leighton JA; Pasha SF; Picco MF; Newberry RD; Achkar JP; Faubion WA
    Clin Transl Gastroenterol; 2023 Sep; 14(9):e00615. PubMed ID: 37440754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
    Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.
    Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR
    Front Immunol; 2020; 11():598152. PubMed ID: 33613519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased TERC gene copy number and cells in senescence in primary sclerosing cholangitis compared to colitis and control patients.
    Laish I; Katz H; Sulayev Y; Liberman M; Naftali T; Benjaminov F; Stein A; Kitay-Cohen Y; Biron-Shental T; Konikoff F; Amiel A
    Gene; 2013 Oct; 529(2):245-9. PubMed ID: 23933276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
    Wohl P; Hucl T; Drastich P; Kamenar D; Spicak J; Honsova E; Sticova E; Lodererova A; Matous J; Hill M; Wohl P; Kucera M
    World J Gastroenterol; 2013; 19(14):2234-41. PubMed ID: 23599650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
    Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
    J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
    Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
    Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
    Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
    Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis.
    Lampinen M; Fredricsson A; Vessby J; Martinez JF; Wanders A; Rorsman F; Carlson M
    J Leukoc Biol; 2018 Jul; 104(1):173-183. PubMed ID: 29603385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study.
    Lundqvist K; Broomé U
    Dis Colon Rectum; 1997 Apr; 40(4):451-6. PubMed ID: 9106695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
    Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
    Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
    J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Khan N; Trivedi C; Shah Y; Cole E; Lewis J; Yang YX
    Inflamm Bowel Dis; 2018 Aug; 24(9):2062-2067. PubMed ID: 29697792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
    Głowacki MK; Zwolińska-Wcisło M; Frączek P; Gomulska M; Owczarek D; Cibor D; Cieśla A; Mach T
    Folia Med Cracov; 2015; 55(2):61-8. PubMed ID: 26839244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.